Status:
COMPLETED
Utility of Residual Syntax Score to Predict Outcome After Acute Myocardial Infarction
Lead Sponsor:
Cairo University
Conditions:
Myocardial Infarction
Eligibility:
All Genders
18-85 years
Brief Summary
The aim of this study is to evaluate the utility of residual syntax score after PCI of the culprit vessel for patients with AMI (STEMI or NSTEMI) to predict 6-months clinical outcomes.
Detailed Description
A- Study Design: Prospective cross-sectional analytic study B- Study Protocol: After attaining written informed consents from eligible STEMI/NSTEMI patients for participation in this observational st...
Eligibility Criteria
Inclusion
- \- Acute myocardial infarction (STEMI or NSTEMI)
Exclusion
- Refusal to participate in the study.
- In case of NSTEMI, patients with unrecognizable culprit lesion will be excluded.
- Patients with previous coronary bypass surgery.
Key Trial Info
Start Date :
November 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
490 Patients enrolled
Trial Details
Trial ID
NCT05392777
Start Date
November 1 2021
End Date
July 1 2022
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University hospitals
Cairo, Egypt, 11815